ニュース

A&W Canada’s Burgers to Beat MS Day is returning for its 17th year to raise funds for MS Canada and its efforts to support ...
MS may increase the risk of Alzheimer's disease, possibly due to changes in the activity of immune T-cells, a new genetic ...
Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.
Columnist Desiree Lama describes how her pill box became essential as her life with multiple sclerosis meant more and more ...
Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.
An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...
People with MS visited doctors, were hospitalized, and used emergency care more than other people decades before their ...
A person's total number of visits to multiple sclerosis clinics is not associated with a lower risk of death, a study on ...
A six-week music-based intervention may reduce psychosocial fatigue and heat pain sensitivity in people with multiple ...
Regular exercise that follows established guidelines for physical activity in MS lead to clinically meaningful improvements ...
Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.
Vibration therapy eases fatigue and improves motor and cognitive outcomes in MS, outperforming standard physical exercise ...